Gene · 26524
Papers2,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analysis unveiled fibroblast-mediated pathogenesis in male genital lichen sclerosus. | Cell Biosci | 2025 | 40745572 | PubTator, text mining | PubMed |
| Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma. | Life Sci Alliance | 2025 | 40744733 | PubTator, text mining | PubMed |
| Knockdown of PVT1 inhibits cell proliferation in luminal and basal-like breast cancer subtypes by activating LATS2/Hippo signaling pathway. | World J Surg Oncol | 2025 | 40684233 | PubTator, text mining | PubMed |
| Matrix Stiffness Regulates TGFβ1-Induced αSMA Expression via a G9a-LATS-YAP Signaling Cascade. | FASEB Bioadv | 2025 | 40661662 | PubTator, text mining | PubMed |
| NCF2 drives tumor progression and metastasis through NR2F2/LATS2/YAP1 axis in esophageal squamous cell carcinoma. | Cancer Lett | 2025 | 40645396 | PubTator, text mining | PubMed |
| miR-127-5p-enriched extracellular vesicles modulate the Hippo pathway to counteract steroid-induced osteonecrosis pathology of the femoral head. | Free Radic Biol Med | 2025 | 40553890 | PubTator, text mining | PubMed |
| Lats1/2 Are Essential for Developmental Vascular Remodeling and Biomechanical Adaptation to Shear Stress. | Arterioscler Thromb Vasc Biol | 2025 | 40501385 | PubTator, text mining | PubMed |
| Gene network changes after exposure to nanoliposomes containing antisense miR-21 and miR-373 in bladder cancer Cells: An in vitro model study. | Biochem Biophys Rep | 2025 | 40469776 | PubTator, text mining | PubMed |
| Imaging methods to monitor and quantify cell differentiation. | Front Cell Dev Biol | 2025 | 40433548 | PubTator, text mining | PubMed |
| Downregulation of HTRA1 Promotes EMT and Anoikis Resistance in Colorectal Cancer via Activation of Hippo/YAP1 Pathway by Facilitating LATS2 Degradation. | Mol Carcinog | 2025 | 40418093 | PubTator, text mining | PubMed |
| Revisiting the molecular landscape of Rosai-Dorfman disease: insights from whole exome sequencing of Saudi patients. | Front Oncol | 2025 | 40406258 | PubTator, text mining | PubMed |
| Novel anoikis-related genes for the diagnosis of non-obstructive azoospermia. | Transl Androl Urol | 2025 | 40376522 | PubTator, text mining | PubMed |
| Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer. | Front Immunol | 2025 | 40260244 | PubTator, text mining | PubMed |
| Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression. | Oncogene | 2025 | 40221530 | PubTator, text mining | PubMed |
| Breast cancer-derived exosomal miR-105-5p facilitates the transformation of NFs into CAFs through LATS2-NF-κB signaling. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40151143 | PubTator, text mining | PubMed |
| Ultraviolet B Exposure Does Not Influence the Expression of YAP mRNA in Human Epidermal Keratinocytes-Preliminary Study. | Biomedicines | 2025 | 40149574 | PubTator, text mining | PubMed |
| Comprehensive profiling of T-cell exhaustion signatures and establishment of a prognostic model in lung adenocarcinoma through integrated RNA-sequencing analysis. | Technol Health Care | 2025 | 40105167 | PubTator, text mining | PubMed |
| Declining activity of serum response factor in aging aorta in relation to aneurysm progression. | J Biol Chem | 2025 | 40081573 | PubTator, text mining | PubMed |
| Curcumin inhibits pancreatic steatosis in mice with a high-fat diet through the YAP/p53 pathway and confirmed through ultrasonic imaging. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | 39988083 | PubTator, text mining | PubMed |
| Mechanism of the microRNA-373-3p/LATS2 Axis in the Prognosis and Metastasis of Thyroid Cancer Patients. | J Biochem Mol Toxicol | 2025 | 39987521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26524/papers?page=4